Skip to content

Clinical trials

Carcinoma, Hepatocellular trials in South Korea with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Status: Unknown status Country / region: South Korea Clear all

40 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20072
20092
20102
20124
20144
20153
20164
20173
20183
20206
20212
20222
20233

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status40

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Seoul National University Hospital16
Asan Medical Center5
CHA University2
Korea University2
Samsung Medical Center2
Yonsei University2
Chung-Ang University1
Eutilex1
Gangneung Asan Hospital1
Hallym University Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular40
Liver Cirrhosis6
Neoplasm Metastasis2
Stomach Neoplasms2
Biliary Tract Neoplasms1
Blood Loss, Surgical1
Cholangiocarcinoma1
Colorectal Neoplasms1
Cryoglobulinemia1
Diabetes Mellitus1

Trials

Showing 1 to 25 of 40. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.